BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 17978525)

  • 1. The effect of sodium alginate on physical and dissolution properties of Surelease-matrix pellets prepared by a novel pelletizer.
    Kim MS; Kim JS; Hwang SJ
    Chem Pharm Bull (Tokyo); 2007 Nov; 55(11):1631-4. PubMed ID: 17978525
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The influence of Surelease and sodium alginate on the in-vitro release of tamsulosin hydrochloride in pellet dosage form.
    Kim MS; Jun SW; Lee S; Lee TW; Park JS; Hwang SJ
    J Pharm Pharmacol; 2005 Jun; 57(6):735-42. PubMed ID: 15969928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of water soluble additives and HPMCP on drug release from Surelease-coated pellets containing tamsulosin hydrochloride.
    Kim MS; Kim JS; Kang SH; Yoo YH; Lee S; Park JS; Woo JS; Hwang SJ
    Arch Pharm Res; 2007 Aug; 30(8):1008-13. PubMed ID: 17879755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alginate-based pellets prepared by extrusion/spheronization: effect of the amount and type of sodium alginate and calcium salts.
    Sriamornsak P; Nunthanid J; Luangtana-anan M; Weerapol Y; Puttipipatkhachorn S
    Eur J Pharm Biopharm; 2008 May; 69(1):274-84. PubMed ID: 17962003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Optimization of preparation process of floating sustained-release pellets of capsaicin based on nanometer CaCO3 by central composite design-response surface method].
    Chen XY; Zhang ZH; Jin X; Jia XB
    Zhongguo Zhong Yao Za Zhi; 2012 Nov; 37(22):3400-5. PubMed ID: 23373210
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The influence of chitosan and sodium alginate and formulation variables on the formation and drug release from pellets prepared by extrusion/spheronisation.
    Chatchawalsaisin J; Podczeck F; Newton JM
    Int J Pharm; 2004 May; 275(1-2):41-60. PubMed ID: 15081137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on the influencing factors on the drug release from sodium alginate matrices].
    Nie SF; Wu XM; Liu HF; Jiang HW; Pan WS
    Yao Xue Xue Bao; 2004 Jul; 39(7):561-5. PubMed ID: 15493851
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design of in situ dispersible and calcium cross-linked alginate pellets as intestinal-specific drug carrier by melt pelletization technique.
    Nurulaini H; Wong TW
    J Pharm Sci; 2011 Jun; 100(6):2248-57. PubMed ID: 21213311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative study of drug release from pellets coated with HPMC or Surelease.
    Sadeghi F; Ford JL; Rubinstein MH; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2000 Jun; 26(6):651-60. PubMed ID: 10826113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-emulsifying excipient platform for improving technological properties of alginate-hydroxypropylcellulose pellets.
    Mannina P; Segale L; Giovannelli L; Bonda AF; Pattarino F
    Int J Pharm; 2016 Feb; 499(1-2):74-80. PubMed ID: 26721727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of formulation and process variables on the release behavior of amoxicillin matrix tablets.
    Tapia-Albarran M; Villafuerte-Robles L
    Drug Dev Ind Pharm; 2004 Sep; 30(8):901-8. PubMed ID: 15521335
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of drug release from pellets coated with Surelease containing hydroxypropylmethylcellulose.
    Sadeghi F; Ford JL; Rubinstein MH; Rajabi-Siahboomi AR
    Drug Dev Ind Pharm; 2001 May; 27(5):419-30. PubMed ID: 11448049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative studies on polyelectrolyte complexes and mixtures of chitosan-alginate and chitosan-carrageenan as prolonged diltiazem clorhydrate release systems.
    Tapia C; Escobar Z; Costa E; Sapag-Hagar J; Valenzuela F; Basualto C; Gai MN; Yazdani-Pedram M
    Eur J Pharm Biopharm; 2004 Jan; 57(1):65-75. PubMed ID: 14729081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of chitosan type on the properties of extruded pellets with low amount of microcrystalline cellulose.
    Charoenthai N; Kleinebudde P; Puttipipatkhachorn S
    AAPS PharmSciTech; 2007 Aug; 8(3):E64. PubMed ID: 17915814
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation and Coating of Alginate and Alginate-Hydroxypropylcellulose Pellets Containing Ranolazine.
    Segale L; Mannina P; Giovannelli L; Muschert S; Pattarino F
    J Pharm Sci; 2016 Nov; 105(11):3351-3358. PubMed ID: 27653554
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimization of tamsulosin hydrochloride controlled release pellets coated with Surelease and neutralized HPMCP.
    Kim MS; Kim JS; Lee S; Jun SW; Park JS; Woo JS; Hwang SJ
    J Pharm Pharmacol; 2006 Dec; 58(12):1611-6. PubMed ID: 17331324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multiunit controlled-release diclofenac sodium capsules using complex of chitosan with sodium alginate or pectin.
    Mitrevej A; Sinchaipanid N; Rungvejhavuttivittaya Y; Kositchaiyong V
    Pharm Dev Technol; 2001 Aug; 6(3):385-92. PubMed ID: 11485180
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coatless alginate pellets as sustained-release drug carrier for inflammatory bowel disease treatment.
    Md Ramli SH; Wong TW; Naharudin I; Bose A
    Carbohydr Polym; 2016 Nov; 152():370-381. PubMed ID: 27516284
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design and evaluation of effervescent floating tablets based on hydroxyethyl cellulose and sodium alginate using pentoxifylline as a model drug.
    Rahim SA; Carter PA; Elkordy AA
    Drug Des Devel Ther; 2015; 9():1843-57. PubMed ID: 25848220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. "Smart" alginate-hydroxypropylcellulose microbeads for controlled release of heparin.
    Karewicz A; Zasada K; SzczubiaƂka K; Zapotoczny S; Lach R; Nowakowska M
    Int J Pharm; 2010 Jan; 385(1-2):163-9. PubMed ID: 19840839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.